AriasDSaxenaSVerguetS.Quantifying the global burden of mental disorders and their economic value. EClinicalMedicine. 2022;54:101675. doi:10.1016/j.eclinm.2022.101675
DhunganaRRPandeyARJoshiS, et al. The burden of mental disorders in Nepal between 1990 and 2019: findings from the Global Burden of Disease Study 2019. Camb Prisms Glob Ment Health. 2023;10:e61. doi:10.1017/gmh.2023.55
PathakNBasyalBJhaP, et al. Drug Act 1978 of Nepal: a critical analysis. J Karnali Acad Health Sci. 2022;5(3). doi:10.61814/jkahs.v5i3.759
23.
SinghRKhadkaS.Mental health law in Nepal. BJPsych Int. 2022;19(1):24-26. doi:10.1192/bji.2021.52
24.
El-DenSCollinsJCChenTFO’reillyCL.Pharmacists’ roles in mental healthcare: past, present and future. Pharm Pract. 2021;19(3):2545. doi:10.18549/PharmPract.2021.3.2545
25.
WerremeyerABostwickJCobbC, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin. 2020;10(6):358-380. doi:10.9740/mhc.2020.11.358
American Association of Psychiatric Pharmacists. Helpful insights for patients and caregivers. 2023. Accessed June 28, 2023. https://aapp.org/resource/patients
29.
American Association of Psychiatric Pharmacists. Social determinants of health. 2023. Accessed June 28, 2023. https://aapp.org/psychpharm/sdoh
30.
American Association of Psychiatric Pharmacists. Addressing the treatment gap for opioid and substance use disorders. 2023. Accessed June 28, 2023. https://aapp.org/advocacy/sud
AldermanCBurgessNEllisDJonesJNigroONyfort-HansenK.SHPA standards for the practice of psychiatric pharmacy: the Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Psychiatric Pharmacy. Aust J Hosp Pharm. 2000;30(6):292-295. doi:10.1002/jppr2000306292
33.
KhanalDP.History of pharmaceutical development in Nepal. J Manmohan Mem Inst Health Sci. 2018;3(1):86-93. doi:10.3126/jmmihs.v3i1.19182
34.
Department of Drug Administration: Home, Ministry of Health and Population. 2025. Accessed May 15, 2025. https://dda.gov.np/
35.
KhadkaSDcMMalekuKThapaP.Implementing hospital pharmacy service guideline in Nepal: a critical analysis. Hosp Pharm. 2023;58(6):527-529. doi:10.1177/00185787231172383
36.
PathakNRasailiABarmaS, et al. Establishment of a drug information unit and pharmacovigilance cell in a Provincial Hospital of Nepal: Implementation of the 2015 hospital pharmacy service guidelines. Hosp Pharm. 2025;60(3):197-201. doi:10.1177/00185787241306689
37.
ShresthaSShakyaDPalaianS.Clinical pharmacy education and practice in Nepal: a glimpse into present challenges and potential solutions. Adv Med Educ Pract. 2020;11:541-548. doi:10.2147/AMEP.S257351
38.
ShresthaRPalaianSSapkotaBShresthaSKhatiwadaAPShankarPR.A nationwide exploratory survey assessing perception, practice, and barriers toward pharmaceutical care provision among hospital pharmacists in Nepal. Sci Rep. 2022;12(1):16590. doi:10.1038/s41598-022-16653-x
39.
MikraniRNaveedMMikraniAYasmeenSAkabarMXiaohuiZ.Correction to: the impact of clinical pharmacy services in Nepal in the context of current health policy: a systematic review. J Public Health. 2020;28(3):257-258. doi:10.1007/s10389-019-01077-1
40.
PathakNBasyalB.Clinical clerkship at an oncology hospital based on the curriculum of a clinical pharmacy program from a university belonging to low-middle-income country: insights from a pharmacy program experience. J Oncol Pharm Pract. 2023;29:1227-1233. doi:10.1177/10781552231174784
KhatiwadaAPShresthaSSapkotaB, et al. Continuing pharmacy education: exploring the status and future prospects in Nepal. Adv Med Educ Pract. 2022;13:419-425. doi:10.2147/AMEP.S353455
43.
UpadhayaNJordansMJDGurungDPokhrelRAdhikariRPKomproeIH.Psychotropic drugs in Nepal: perceptions on use and supply chain management. J Glob Health. 2018;14(1):10. doi:10.1186/s12992-018-0322-4
44.
AdhikariSRPradhanSNSharmaSC.Experiencing stigma: Nepalese perspectives. Kathmandu Univ Med J. 1970;6(4):458-465. doi:10.3126/kumj.v6i4.1736